Atnaujinkite slapukų nuostatas

Red Book®: 2018-2021 Report of the Committee on Infectious Diseases 31st Revised edition [Minkštas viršelis]

  • Formatas: Paperback / softback, 1213 pages, aukštis x plotis: 229x152 mm
  • Išleidimo metai: 30-Apr-2018
  • Leidėjas: American Academy of Pediatrics
  • ISBN-10: 1610021460
  • ISBN-13: 9781610021463
Kitos knygos pagal šią temą:
  • Formatas: Paperback / softback, 1213 pages, aukštis x plotis: 229x152 mm
  • Išleidimo metai: 30-Apr-2018
  • Leidėjas: American Academy of Pediatrics
  • ISBN-10: 1610021460
  • ISBN-13: 9781610021463
Kitos knygos pagal šią temą:
The AAP's authoritative guide on preventing, recognizing, and treating more than 200 childhood infectious diseases. Developed by the AAP's Committee on Infectious Diseases as well as the expertise of the CDC, the FDA, and hundreds of physician contributors.


Extending an 8-decade tradition of excellence, Red Book® provides the most reliable and clinically useful information on the manifestations, etiology, epidemiology, diagnosis and treatment of more than 200 childhood infectious diseases.

The 31st edition provides evidence-based guidance to practicing clinicians on pediatric infections and vaccinations based on the recommendations of the committee as well as the combined expertise of the CDC, the FDA, and hundreds physician contributors.

New in Red Book 2018:


All chapters were assessed for relevance given the dynamic environment in pediatric medicine today and every chapter has been modified since the last edition

  • 3 new chapters added (Chikungunya, Coagulase-Negative Staphylococcal Infections, and Zika).
  • Standardized approaches to disease prevention through immunizations, antimicrobial prophylaxis, and infection-control practices have been updated throughout
  • Recommendations for the use of doxycycline have been liberalized.
  • References to evidence-based policy recommendations have been recommended
  • Appropriate chapters have been updated to be consistent with 2018 AAP and CDC vaccine recommendations, CDC recommendations for immunization of health care personnel, and drug recommendations from 2018 Nelson's Pediatric Antimicrobial Therapy.
 
Red Book® is an indispensable reference for pediatricians and pediatric infectious disease specialists and is useful for family medicine and emergency medicine physicians as well. Public health and school health professionals, medical residents, and students also will find it a high-yield source of pediatric infectious disease and vaccine information.
 

Recenzijos

Red Book® has been selected as one of Doodys Core Titles®

"The Red Book is the preeminent resource on pediatric infectious disease. This book is a must for anyone seeing pediatric patients in a clinical setting. It should be on the desks of everyone who cares for children, from nurses and midlevel providers to physicians and trainees. There is just no other comparable resource available on pediatric infectious diseases." Doody's 5* Book Review, reviewed by Maria Alcocer Alkureishi, MD (University of Chicago Pritzker School of Medicine)

Summary of Major Changes in the 2018 Red Book xxxv
Section 1 Active And Passive Immunization
Prologue
1(2)
Sources of Information About Immunization
3(4)
Discussing Vaccines With Patients and Parents
7(6)
Addressing Parents' Questions About Vaccine Safety and Effectiveness
7(1)
Common Misconceptions About Immunizations and the Institute of Medicine Findings
7(1)
Resources for Optimizing Communications With Parent About Vaccines
8(3)
Parental Refusal of Immunizations
11(2)
Active Immunization
13(42)
Vaccine Ingredients
17(3)
Vaccine Handling and Storage
20(6)
Vaccine Administration
26(4)
Managing Injection Pain
30(1)
Timing of Vaccine's and the Immunization Schedule
31(3)
Minimum Ages and Minimum Intervals Between Vaccine Doses
34(1)
Interchangeability of Vaccine Products
34(1)
Simultaneous Administration of Multiple Vaccines
35(1)
Combination Vaccines
36(2)
Lapsed Immunizations
38(1)
Unknown or Uncertain Immunization Status
38(1)
Vaccine Dose
38(1)
Active Immunization of People Who Recently Received Immune Globulin and Other Blood Products
39(2)
Vaccine Safety
41(14)
Risks and Adverse Events
41(2)
Institute of Medicine Reviews of Adverse Events After Immunization
43(2)
Vaccine Adverse Event Reporting System
45(1)
Vaccine Safety Datalink Project
46(3)
Post-Licensure Rapid Immunization Safety Monitoring (PRISM)
49(1)
Clinical Immunization Safety Assessment (LISA) Project
50(1)
Vaccine Injury Compensation
51(1)
Hypersensitivity Reactions After Immunization
52(1)
Immediate-Type Allergic Reactions
53(1)
Delayed-Type Allergic Reactions
54(1)
Other Vaccine Reactions
54(1)
Passive Immunization
55(12)
Immune Globulin Intramuscular (IGIM)
56(2)
Immune Globulin Intravenous (IG1V)
58(4)
Immune Globulin Subcutaneous (IGSC)
62(2)
Treatment of Anaphylactic Reactions
64(3)
Immunization in Special Clinical Circumstances
67(46)
Immunization in Preterm and Low Birth Weight Infants
67(2)
Immunization in Pregnancy
69(3)
Immunization and Other Considerations in Immunocompromised Children
72(19)
Immunization in Children With a Personal or Family History of Seizures
91(1)
Immunization in Children With Chronic Diseases
92(1)
Immunization in American Indian/Alaska Native Children and Adolescents
93(2)
Immunization in Adolescent and College Populations
95(2)
Immunization in Health Care Personnel
97(3)
Children Who Received Immunizations Outside the United States or Whose Immunization Status is Unknown or Uncertain
100(3)
International Travel
103(10)
Section 2 Recommendations For Care Of Children In Special Circumstances
Human Milk
113(9)
Immunization of Mothers and Infants
114(1)
Transmission of Infectious Agents via Human Milk
115(6)
Antimicrobial Agents and Other Drugs in Human Milk
121(1)
Biologic Response Modifiers in Human Milk
121(1)
Children in Out-of-Home Child Care
122(14)
Modes of Spread of Infectious Diseases
122(3)
Management and Prevention of Infectious Diseases
125(11)
School Health
136(11)
Diseases Preventable by Routine Childhood Immunization
138(2)
Infections Spread by the Respiratory Route
140(1)
Infections Spread by Direct Contact
141(2)
Infections Spread by the Fecal-Oral Route
143(1)
Infections Spread by Blood and Body Fluids
144(3)
Infection Control and Prevention for Hospitalized Children
147(16)
Isolation Precautions
148(10)
Strategies to Prevent Health Care-Associated Infections
158(1)
Occupational Health
159(1)
Sibling Visitation
160(1)
Adult Visitation
161(1)
Pet Visitation
161(2)
Infection Control and Prevention in Ambulatory Settings
163(2)
Sexually Transmitted Infections in Adolescents and Children
165(11)
STIs in Adolescents
165(3)
STIs in Children
168(8)
Medical Evaluation for Infectious Diseases for Internationally Adopted, Refugee, and Immigrant Children
176(9)
Consideration for Testing for Infectious Agents
178(7)
Hepatitis A
178(1)
Hepatitis B
179(1)
Hepatitis C
179(1)
Intestinal Pathogens
180(1)
Tissue Parasites/Eosinophilia
181(1)
Syphilis
181(1)
Tuberculosis
182(1)
HIV Infection
183(1)
Chagas Disease (American Trypanosomiasis)
183(1)
Other Infectious Diseases
184(1)
Injuries From Discarded Needles in the Community
185(4)
Wound Care and Tetanus Prophylaxis
186(1)
Bloodborne Pathogens
186(3)
Preventing Needlestick Injuries
189(1)
Bite Wounds
189(6)
Prevention of Mosquitoborne and Tickborne Infections
195(6)
General Protective Measures
196(1)
Repellents for Use on Skin
197(3)
Tick Inspection and Removal
200(1)
Other Preventive Measures
200(1)
Prevention of Illnesses Associated with Recreational Water Use
201(4)
Section 3 Summaries Of Infectious Diseases
Actinomycosis
205(1)
Adenovirus Infections
206(2)
Amebiasis
208(3)
Amebic Meningoencephalitis and Keratitis
211(3)
Anthrax
214(6)
Arboviruses
220(7)
Arcanobacterium haemolyticum Infections
227(1)
Ascaris lumbricoides Infections
228(2)
Aspergillosis
230(4)
Astrovirus Infections
234(1)
Babesiosis
235(2)
Bacillus cereus Infections and Intoxications
237(2)
Bacterial Vaginosis
239(3)
Bacteroides, Prevotella, and Other Anaerobic Gram-Negative Bacilli Infections
242(1)
Balantidium coli Infections (Balantidiasis)
243(1)
Bartonella henselae (Cat-Scratch Disease)
244(3)
Baylisascaris Infections
247(1)
Infections With Blastocystis hominis and Other Subtypes
248(1)
Blastomycosis
249(2)
Bocavirus
251(1)
Borrelia Infections Other Than Lyme Disease (Relapsing Fever)
252(3)
Brucellosis
255(3)
Burkholderia Infections
258(2)
Campylobacter Infections
260(3)
Candidiasis
263(6)
Chancroid and Cutaneous Ulcers
269(2)
Chikungunya
271(2)
Chlamydial Infections
273(10)
Chlamydia pneumoniae
273(1)
Chlamydia psittaci (Psittacosis, Ornithosis, Parrot Fever)
274(2)
Chlamydia trachomatis
276(7)
Clostridial Infections
283(11)
Botulism and Infant Botulism (Clostridium botulinum)
283(3)
Clostridial Myonecrosis (Gas Gangrene)
286(2)
Clostridium difficile
288(4)
Clostridium peringens Food Poisoning
292(2)
Coccidioidomycosis
294(3)
Coronaviruses, Including SARS and MERS
297(4)
Cryptococcus neoformans and Cryptococcus gattii Infections (Cryptococcosis)
301(3)
Cryptosporidiosis
304(3)
Cutaneous Larva Migrans
307(1)
Cyclosporiasis
308(1)
Cystoisosporiasis (Formerly Isosporiasis)
309(1)
Cytomegalovirus Infection
310(7)
Dengue
317(2)
Diphtheria
319(4)
Ehrlichia, Anaplasma, and Related Infections (Human Ehrlichiosis, Anaplasmosis, and Related Infections Attributable to Bacteria in the Family Anaplasmataceae)
323(5)
Serious Bacterial Infections Caused by Enterobacteriaceae (With Emphasis on Septicemia and Meningitis in Neonates)
328(3)
Enterovirus (Nonpoliovirus) (Group A and B Coxsackieviruses, Echoviruses, Numbered Enteroviruses)
331(3)
Epstein-Barr Virus Infections (Infectious Mononucleosis)
334(4)
Escherichia coli Diarrhea (Including Hemolytic-Uremic Syndrome)
338(6)
Other Fungal Diseases
344(6)
Fusobacterium Infections (Including Lemierre Disease)
350(2)
Giardia intestinalis (formerly Giardia lamblia and Giardia duodenalis) Infections (Giardiasis)
352(3)
Gonococcal Infections
355(10)
Granuloma Inguinale (Donovanosis)
365(2)
Haemophilus influenzae Infections
367(8)
Hantavirus Pulmonary Syndrome
375(3)
Helicobacter pylori Infections
378(3)
Hemorrhagic Fevers Caused by Arenaviruses
381(3)
Hemorrhagic Fevers Caused by Bunyaviruses
384(3)
Hemorrhagic Fevers Caused by Filoviruses: Ebola and Marburg
387(5)
Hepatitis A
392(9)
Hepatitis B
401(27)
Hepatitis C
428(6)
Hepatitis D
434(2)
Hepatitis E
436(1)
Herpes Simplex
437(12)
Histoplasmosis
449(4)
Hookworm Infections (Ancylostoma duodenale and Necator americanus)
453(1)
Human Herpesvirus 6 (Including Roseola) and 7
454(3)
Human Herpesvirus 8
457(2)
Human Immunodeficiency Virus Infection
459(17)
Influenza
476(14)
Kawasaki Disease
490(7)
Kingella kingae Infections
497(1)
Legionella pneumophila Infections
498(3)
Leishmaniasis
501(3)
Leprosy
504(4)
Leptospirosis
508(3)
Listeria monocytogenes Infections (Listeriosis)
511(4)
Lyme Disease (Lyme Borreliosis, Borrelia burgdoeri sensu lato Infection)
515(8)
Lymphatic Filariasis (Bancroftian, Malayan, and Timorian)
523(2)
Lymphocytic Choriomeningitis
525(2)
Malaria
527(10)
Measles
537(13)
Meningococcal Infections
550(11)
Human Metapneumovirus
561(2)
Microsporidia Infections (Microsporidiosis)
563(2)
Molluscum Contagiosum
565(1)
Moraxella catarrhalis Infections
566(1)
Mumps
567(6)
Mycoplasma pneumoniae and Other Mycoplasma Species Infections
573(2)
Nocardiosis
575(2)
Norovirus and Sapovirus Infections
577(3)
Onchocerciasis (River Blindness, Filariasis)
580(2)
Human Papillomaviruses
582(8)
Paracoccidioidomycosis (Formerly Known as South American Blastomycosis)
590(1)
Paragonimiasis
591(2)
Parainfluenza Viral Infections
593(2)
Parasitic Diseases
595(6)
Human Parechovirus Infections
601(1)
Parvovirus B19 (Erythema Infectiosum, Fifth Disease)
602(4)
Pasteurella Infections
606(1)
Pediculosis Capitis (Head Lice)
607(5)
Pediculosis Corporis (Body Lice)
612(1)
Pediculosis Pubis (Pubic Lice, Crab Lice)
613(1)
Pelvic Inflammatory Disease
614(6)
Pertussis (Whooping Cough)
620(14)
Pinworm Infection (Enterobius vermiculaiis)
634(1)
Pityriasis Versicolor (Formerly Tinea Versicolor)
635(2)
Plague
637(2)
Pneumococcal Infections
639(12)
Pneumocystis jirovecii Infections
651(6)
Poliovirus Infections
657(7)
Polyomaviruses (BK, JC, and Other Polyomaviruses)
664(2)
Prion Diseases: Transmissible Spongiform Encephalopathies
666(5)
Q Fever (Coxiella burnetii Infection)
671(2)
Rabies
673(7)
Rat-Bite Fever
680(2)
Respiratory Syncytial Virus
682(10)
Rhinovirus Infections
692(1)
Rickettsial Diseases
693(3)
Rickettsialpox
696(1)
Rocky Mountain Spotted Fever
697(3)
Rotavirus Infections
700(5)
Rubella
705(6)
Salmonella Infections
711(7)
Scabies
718(3)
Schistosomiasis
721(2)
Shigella Infections
723(4)
Smallpox (Variola)
727(3)
Sporotrichosis
730(2)
Staphylococcal Food Poisoning
732(1)
Staphylococcus aureus
733(13)
Coagulase-Negative Staphylococcal Infections
746(2)
Group A Streptococcal Infections
748(14)
Group B Streptococcal Infections
762(6)
Non-Group A or B Streptococcal and Enterococcal Infections
768(4)
Strongyloidiasis (Strongyloides stercoralis)
772(1)
Syphilis
773(15)
Tapeworm Diseases (Taeniasis and Cysticercosis)
788(3)
Other Tapeworm Infections (Including Hydatid Disease)
791(2)
Tetanus (Lockjaw)
793(5)
Tinea Capitis (Ringworm of the Scalp)
798(3)
Tinea Corporis (Ringworm of the Body)
801(3)
Tinea Cruris (Jock Itch)
804(2)
Tinea Pedis and Tinea Unguium (Onychomycosis) (Athlete's Foot, Ringworm of the Feet)
806(2)
Toxocariasis (Visceral Toxocariasis [ a Form of Visceral Larva Migrans], Ocular Toxocariasis [ a Form of Ocular Larva Migrans])
808(1)
Toxoplasma gondii Infections (Toxoplasmosis)
809(10)
Trichinellosis (Trichinella spiralis and Other Species)
819(1)
Trichomonas vaginalis Infections (Trichomoniasis)
820(3)
Trichuriasis (Whipworm Infection)
823(1)
African Trypanosomiasis (African Sleeping Sickness)
824(2)
American Trypanosomiasis (Chagas Disease)
826(3)
Tuberculosis
829(24)
Nontuberculous Mycobacteria (Environmental Mycobacteria, Mycobacteria Other Than Mycobacterium tuberculosis)
853(8)
Tularemia
861(3)
Endemic Typhus (Murine Typhus)
864(1)
Epidemic Typhus (Louseborne or Sylvatic Typhus)
865(2)
Ureaplasma urealyticum and Ureaplasma parvum Infections
867(2)
Varicella-Zoster Virus Infections
869(14)
Vibrio Infections
883(5)
Cholera (Vibrio cholerae)
883(4)
Other Vibrio Infections
887(1)
West Nile Virus
888(3)
Yersinia enterocolitica and Yersinia pseudotuberculosis Infections (Enteritis and Other Illnesses)
891(3)
Zika Virus
894(9)
Section 4 Antimicrobial Agents And Related Therapy
Introduction
903(3)
Fluoroquinolones
904(1)
Tetracyclines
905(1)
Other Agents
906(1)
Antimicrobial Resistane and Antimicrobial Stewardship: Appropriate and Judicious Use of Antimicrobial Agents
906(7)
Antimicrobial Resistance
906(1)
Factors Contributing to Resistance
907(1)
Antimicrobial Resistance Threats
907(1)
Actions to Prevent or Slow Antimicrobial Resistance
908(1)
Antimicrobial Stewardship
909(1)
Role of the Medical Provider
910(1)
Principles of Appropriate Use of Antimicrobial Therapy for Upper Respiratory Tract Infections
910(3)
Drug Interactions
913(1)
Tables of Antibacterial Drug Dosages
914(19)
Sexually Transmitted Infections
933(5)
Antifungal Drugs for Systemic Fungal Infections
938(7)
Polyenes
938(2)
Pyrimidines
940(1)
Azoles
940(1)
Echinocandins
941(4)
Recommended Doses of Parenteral and Oral Antifungal Drugs
945(11)
Topical Drugs for Superficial Fungal Infections
956(10)
Non-HIV Antiviral Drugs
966(19)
Drugs for Parasitic Infections
985(41)
MedWatch-The FDA Safety Information and Adverse Event-Reporting Program
1026(3)
Section 5 Antimicrobial Prophylaxis
Antimicrobial Prophylaxis
1029(2)
Infection-Prone Body Sites
1029(2)
Exposure to Specific Pathogens
1031(1)
Vulnerable Hosts
1031(1)
Antimicrobial Prophylaxis in Pediatric Surgical Patients
1031(13)
Guidelines for Appropriate Use
1032(1)
Indications for Prophylaxis
1032(2)
Surgical Site Infection Criteria
1034(1)
Timing of Administration of Prophylactic Antimicrobial Agents
1035(1)
Dosing and Duration of Administration of Antimicrobial Agents
1035(1)
Preoperative Screening and Decolonization
1035(1)
Recommended Antimicrobial Agents
1035(9)
Prevention of Bacterial Endocarditis
1044(2)
Prevention of Neonatal Ophthalmia
1046(5)
Gonococcal Ophthalmia
1046(1)
Chlamydial Ophthalmia
1047(1)
Pseudomonal Ophthalmia
1047(1)
Other Nongonococcal, Nonchlamydial Ophthalmia
1048(1)
Administration of Neonatal Ophthalmic Prophylaxis
1049
Appendices
I Directory of Resources
1051(6)
II Codes for Commonly Administered Pediatric Vaccines/Toxoids and Immune Globulins
1057(1)
III Vaccine Injury Table
1058(11)
IV Nationally Notifiable Infectious Diseases in the United States
1069(2)
V Guide to Contraindications and Precautions to Immunizations
1071(11)
VI Prevention of Disease From Contaminated Food Products
1082(4)
VII Clinical Syndromes Associated With Foodborne Diseases
1086(7)
VIII Diseases Transmitted by Animals (Zoonoses)
1093
David W. Kimberlin, MD, FAAP is the Principal Investigator for the Collaborative Antiviral Study Group (CASG), an international network of pediatric academic medical centers that evaluates antiviral therapeutics in rare diseases with a large unmet medical need, including neonatal herpes simplex virus (HSV) infections, congenital cytomegalovirus (CMV) disease, congenital Zika infection, neonatal and infantile influenza infection, and neonatal enteroviral sepsis syndrome. Studies conducted by the CASG have led to new drug indications and label changes for acyclovir, valganciclovir, and oseltamivir, and non-CASG studies conducted by Dr. Kimberlin also have led to label changes for valacyclovir.   Dr. Kimberlin is Editor of the 2018 AAP Report of the Committee on Infectious Diseases (Red Book). He also was Editor of the 2015 edition, and was an Associate Editor of the 2012 and 2009 editions. Dr. Kimberlin is a Past-President of the Pediatric Infectious Diseases Society (PIDS), which is the world's largest organization of professionals dedicated to the treatment, control, and eradication of infectious diseases affecting children. He also serves as Vice Chair for Clinical and Translational Research in the UAB Department of Pediatrics, where he holds the Sergio Stagno Endowed Chair in Pediatric Infectious Diseases and is Co-Director of the Division of Pediatric Infectious Diseases.

Sarah S. Long, MD, FAAP is Section Chief of Infectious Diseases at St. Christophers Hospital for Children in Philadelphia, PA. Dr. Long is also Professor of Pediatrics at Drexel University College of Medicine. Dr. Long is an associate editor of The Journal of Pediatrics and is the chief editor of the textbook Principles and Practice of Pediatric Infectious Diseases. She has received numerous teaching awards, the Distinguished Service Award of the Pediatric Infectious Diseases Society, the Clinical Teacher Award of the Infectious Diseases Society of America, and the Award for Lifetime Contribution to Infectious Diseases Education by the Section on Infectious Diseases of the American Academy of Pediatrics.Dr. Long completed her medical degree at Jefferson Medical College in Philadelphia, and her residency and fellowship at St. Christophers Hospital for Children. She is board certified in pediatrics and pediatric infectious disease, and her principal areas of research are vaccine-preventable diseases and management of common infectious diseases in children. She sits on advisory committees for the National Institutes of Health, the Food and Drug Administration and the Centers for Disease Control and Prevention.

Michael T. Brady MD, FAAP is Professor of Pediatrics at The Ohio State University and Associate Medical Director at Nationwide Childrens Hospital. Dr. Brady was on the AAP Committee on Infectious Diseases from 2005 until 2014 (Chair from 2010 to 2014). Dr. Brady was an Associate Editor of the 2015 Red Book. Dr. Brady received his medical degree from Jefferson Medical College in Philadelphia. His pediatric residency was completed at Nationwide Childrens Hospital in Columbus, Ohio and Baylor College of Medicine in Houston. His pediatric infectious diseases fellowship was at the Baylor College of Medicine. Dr. Bradys special interests include HIV infection, healthcare-associated infections, perinatal infections and vaccine-preventable infections. He is currently a member of the Board of Scientific Counselors Infectious Diseases at the Centers for Disease Control and Prevention.

Mary Anne Jackson, MD, FAAP: Following residency at Cincinnati Childrens and fellowship at the University of Texas Southwestern, Dr. Jackson has been a faculty member at Childrens Mercy Hospital, Kansas City since 1984 where she is Division Director of Infectious Diseases. She has won numerous teaching awards and was honored in 2012 as the outstanding graduate at the University of Missouri-Kansas City School of Medicine. A fellow of the AAP, the Infectious Disease Society of America and the Pediatric Infectious Disease Society, she has also been elected to the American Pediatric Society, the Society of Pediatric Research and the Academic Pediatric Association. She has been a member of the AAP Committee on Infectious Diseases since 2009, and is an Associate Editor of Red Book 2015. She has authored over 150 peer reviewed publications focusing on strategies to reduce the incidence of hospital acquired infection, judicious use of antibiotics, prevention of antibiotic resistant infection and vaccine implementation and education.